Atlas Trials

Prospective Evaluation of De-Escalation From antiCD-20 Therapies to Dimethyl Fumarate (Tecfidera) or Diroximel Fumarate (Vumerity)

Clinical trial NCT07757568 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07757568
Sponsor
University of Colorado, Denver
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Multiple Sclerosis (MS) Relapsing Remitting
Start date
2023-03-07
Primary completion
2026-09-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.